Literature DB >> 19402181

Establishment of liquid chromatography/mass spectrometry for determination of bicyclol in rat single-pass intestinal perfusion.

Wei Tan1, Bao-Lian Wang, Jin-Ping Hu, Li Sheng, Yan Li.   

Abstract

A simple, rapid and sensitive method was developed for determination of bicyclol, a new synthetic anti-hepatitis drug, in rat plasma from the mesenteric vein using a high-performance liquid chromatography system coupled to a positive ion electrospray-mass spectrometric analysis. Bicyclol and internal standard (biphenyldicarboxylate, DDB) were isolated from plasma by liquid-liquid extraction, then separated on a Zorbax SB-C(18) column (3.5 microm, 2.1 x 100 mm) with mobile phase of methanol-water (60:40, v/v) at a flow rate of 0.2 mL/min. Detection was performed on a Trap XCT mass spectrometer equipped with an electrospray ionization (ESI) source operated in selected ion monitoring mode. Positive ion ESI was used to form sodium adduct molecular ions at m/z 413 for bicyclol and m/z 441 for DDB, respectively. A linear detection response was obtained for bicyclol ranging from 3.3 to 333.3 ng/mL and the lower limit of quantitation was 3.3 ng/mL. The coefficients of variation for intra- and inter-day precisions were 1.1-7.7 and 2.0-6.6%, respectively. The percentage of absolute recovery of bicyclol was 85.3-94.6%. All analytes proved to be stable during all sample storage, preparation and analytic procedures. The method was successfully applied to determine the plasma concentration of bicyclol in mesenteric vein after intestinal perfusion. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19402181     DOI: 10.1002/bmc.1223

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  1 in total

1.  The Cytochrome P450-Mediated Metabolism Alternation of Four Effective Lignans From Schisandra chinensis in Carbon Tetrachloride-Intoxicated Rats and Patients With Advanced Hepatocellular Carcinoma.

Authors:  Rongrong Wu; Zhiyong Xiao; Xiaorui Zhang; Feng Liu; Wenxia Zhou; Yongxiang Zhang
Journal:  Front Pharmacol       Date:  2018-03-14       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.